FR3104438B1 - Formulation pour le bleu de methylene et procede - Google Patents
Formulation pour le bleu de methylene et procede Download PDFInfo
- Publication number
- FR3104438B1 FR3104438B1 FR1914303A FR1914303A FR3104438B1 FR 3104438 B1 FR3104438 B1 FR 3104438B1 FR 1914303 A FR1914303 A FR 1914303A FR 1914303 A FR1914303 A FR 1914303A FR 3104438 B1 FR3104438 B1 FR 3104438B1
- Authority
- FR
- France
- Prior art keywords
- grains
- formulation
- active principle
- film
- phenothiazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention se rapporte à un procédé de fabrication d’une formulation solide gastro-résistante de principe actif à base de phénothiazine, à une formulation obtenue par ce procédé, notamment à une formulation comprenant de 20 à 80% de bleu de méthylène, par exemple sous forme de grains ou de comprimé, ainsi qu’à la formulation de l’invention pour une utilisation comme médicament, notamment dans traitement du paludisme. Le procédé de l’invention comprend (a) l’obtention de grains de principe actif à base de phénothiazine par granulation humide d’un mélange initial comprenant, en % en poids par rapport au poids total du mélange initial de 25 à 85 % de principe actif à base de phénothiazine sous forme de poudre tamisée afin d’éliminer les amas, de 1 à 5 % d’un désintégrant, de 1 à 60 % d’un diluant, et de 1 à 20 % d’un liant ; (b) un séchage des grains de principe actif à base de phénothiazine obtenus ; (c) éventuellement, l’obtention de comprimés par compression des grains de principe actif séchés à partir d’un mélange de compression comprenant en % en poids par rapport au poids total du mélange de 30 à 80 % desdits grains séchés, de 1 à 15 % d’un désintégrant, de 5 à 70% d’un diluant identique ou différent de celui utilisé à l’étape (a), et le reste étant un lubrifiant et un agent d’écoulement ; (d) un pelliculage des grains séchés ou des comprimés au moyen d’un premier agent de pelliculage ; et (e) un pelliculage gastro-résistant desdits grains pelliculés ou comprimés pelliculés obtenus à l’étape (d).
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1914303A FR3104438B1 (fr) | 2019-12-12 | 2019-12-12 | Formulation pour le bleu de methylene et procede |
PCT/FR2020/052378 WO2021116611A1 (fr) | 2019-12-12 | 2020-12-10 | Formulation pour le bleu de methylene et procede |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1914303 | 2019-12-12 | ||
FR1914303A FR3104438B1 (fr) | 2019-12-12 | 2019-12-12 | Formulation pour le bleu de methylene et procede |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3104438A1 FR3104438A1 (fr) | 2021-06-18 |
FR3104438B1 true FR3104438B1 (fr) | 2021-11-19 |
Family
ID=69743504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1914303A Expired - Fee Related FR3104438B1 (fr) | 2019-12-12 | 2019-12-12 | Formulation pour le bleu de methylene et procede |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3104438B1 (fr) |
WO (1) | WO2021116611A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024061971A1 (fr) * | 2022-09-21 | 2024-03-28 | Wista Laboratories Ltd. | Nouvelles formulations et véhicules |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007086079A2 (fr) * | 2006-01-25 | 2007-08-02 | Astron Research Limited | Forme de dose a liberation soutenue de derives de phenothiazine contenant un canalisateur |
SG190406A1 (en) * | 2010-11-30 | 2013-06-28 | Wista Lab Ltd | Formulations comprising methylthioninium chloride |
CA3043451A1 (fr) * | 2016-11-28 | 2018-05-31 | Cosmo Technologies Ltd. | Composition orale solide contenant des colorants |
-
2019
- 2019-12-12 FR FR1914303A patent/FR3104438B1/fr not_active Expired - Fee Related
-
2020
- 2020-12-10 WO PCT/FR2020/052378 patent/WO2021116611A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021116611A1 (fr) | 2021-06-17 |
FR3104438A1 (fr) | 2021-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5416586B2 (ja) | コーティング製剤の製造方法 | |
JP6030643B2 (ja) | ガン細胞の増殖を阻害するアミド誘導体および非金属塩滑沢剤を含む医薬組成物 | |
RU2384328C2 (ru) | Галеновы составы органических соединений | |
EA201892836A1 (ru) | Составы 2-[3-[4-амино-3-(2-фтор-4-феноксифенил)пиразол[3,4-d]пиримидин-1-ил]пиперидин-1-карбонил]-4-метил-4-[4-(оксетан-3-ил)пиперазин-1-ил]пент-2-еннитрила с модифицированным высвобождением | |
SI1931316T1 (sl) | Farmacevtski sestavki z nadzorovanim sproščanjem za kislinsko labilna zdravila | |
CA2577288A1 (fr) | Chlorhydrate de 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethyl-phenyl]amino]-2-pyrimidinyl]amino]benzonitrile | |
FR3104438B1 (fr) | Formulation pour le bleu de methylene et procede | |
US20120157580A1 (en) | Coating composition | |
FR2677886A1 (fr) | Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale. | |
CZ299859B6 (cs) | Farmaceutická formulace a zpusob její prípravy | |
US20070134315A1 (en) | Orally administrable extended release pellet and tablet formulations of a highly water soluble compound | |
JP2009089982A (ja) | 打錠用造粒物の造粒方法 | |
CA2682638A1 (fr) | Composition pharmaceutique comportant de l'isobutyrate de (2r,3s,4r,5r)-5-(4-amino-2-oxo-2h-pyrimidin-1-yl)-2-azido-3,4-bis(isobutyryloxy)-tetrahydrofuran-2-ylmethyle | |
US10561628B2 (en) | Solid preparation including antioxidant | |
RU2009140792A (ru) | Новые стабильные фармацевтические композиции клопидогрель бисульфата и способ их получения | |
JP2017203013A (ja) | エゼチミブ含有医薬組成物及びその製造方法、エゼチミブ含有医薬組成物の硬度低下抑制剤及び硬度低下抑制方法、並びにエゼチミブ含有医薬組成物の吸湿抑制剤及び吸湿抑制方法 | |
JP2023033395A (ja) | ラメルテオン含有フィルムコーティング錠剤 | |
JP2019034929A (ja) | エソメプラゾールマグネシウム水和物を含有する腸溶性コーティング製剤、およびその製造方法 | |
RU2011145436A (ru) | Композиции с немедленным высвобождением лекарственного средства | |
JP2017525735A5 (fr) | ||
JP2018500324A5 (fr) | ||
JP2007169273A (ja) | 杵付着を改善した医薬製剤 | |
FR2584265A1 (fr) | Application de melanges herbicides de derives imidazolinyl-quinoline carboxiliques et phenoxybenzoiques | |
RU2018129198A (ru) | Фармацевтические композиции | |
HRP20120499T1 (hr) | Fumarat cijanoetenil dimetilfenil amino pirimidinil amino benzonitrila |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20210618 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
ST | Notification of lapse |
Effective date: 20230808 |